CK
Therapeutic Areas
GenZum Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Complex Generic / 505(b)(2) Pipeline | Various (Oncology, Immunology, and other areas) | Pre-clinical to Phase 3 (Bioequivalence) |
| Drug | Indication | Phase |
|---|---|---|
| Complex Generic / 505(b)(2) Pipeline | Various (Oncology, Immunology, and other areas) | Pre-clinical to Phase 3 (Bioequivalence) |